Pricing

Sygnature Discovery Limited

2 followers

‌

Sygnature Discovery are a leading drug discovery CRO with expertise across a range of therapeutic and biological target classes. An expert partner in disciplines including Medicinal and Computational Chemistry, In Vitro and In Vivo Pharmacology, DMPK, supported by informatics.

Industries

Headquarters

Nottingham, United Kingdom

Employees

Links

Org chart

Founder, CEO & Director

Simon Hirst

Collapse

Jonathan Williams

COO & Director

Louisa Jordison

CFO & Director

CTO

Chief Scientific Officer

VP, Oncology Drug Discovery

VP, Immunology & Inflammation Drug Discovery

VP, Neuroscience Drug Discovery

VP, Hit ID Technologies

VP, Commercial Services

Director of Chemistry

Colin Sambrook Smith

Director of Computational Sciences & Informatics

Director of Translational Oncology

Director, Form & Formulation

Director DMPK

Claire Ellis-Ross

Manager Of Internal Communications

Senior Scientist

Aparna Chandrasekaran

Senior Scientist

Senior Scientist

Senior Scientist 2

Indranil Duttagupta

Lead Scientist

James Engleback

Senior Scientist

Katarzyna Kopycka

Senior Scientist 1

Martin Lau Christiansen

Senior Scientist

Senior Vice President Human Resources

Teams

Scientists Team

45 members

Leadership Team

9 members

Discovery and Drug Development

9 members

Human Resources & People Operations

5 members

Directors Team

5 members

Legal and Compliance

3 members

Offices

This company has no offices yet

Similar companies

AstraZeneca

338 followers

GSK

297 followers

VIRIXENE

123 followers

Dechra Pharmaceuticals

6 followers

Squarepoint Capital

17 followers

Mundipharma

5 followers

Smith+Nephew

29 followers

Servier Pharmaceuticals

2 followers

KalVista Pharmaceuticals

2 followers

Oncopeptides AB

2 followers

Recursion Pharmaceuticals

10 followers

Explore companies